Mr J B Gupta, Senior VP, GVK Biosciences
Titled, ‘Drug Discovery - How is India doing?', the topic was presented by Mr J B Gupta, Senior VP, GVK Biosciences.
In his presentation, Mr Gupta presented the major milestones achieved based on which drug discovery progress is measured.
He mentioned the following milestones: Post TRIPS and focus on drug discovery (1994); out-licensing of proprietary molecules (1998); discover progress collaboration (2003); and launch of proprietary molecules (2012).
He said, "Drug discovery process and expertise should address the issues and challenges. When there is an unmet need, you need to understand the disease pathology, and then you discover a molecule and carry out trials."
Mr Gupta said that new drug R&D has been started by several Indian pharma companies but it has been very difficult to discover a molecule up to the launch.